Evidence map›Paper›PMID 24358341›Full record

ArticlePloS one2013

ERK5 activation by Gq-coupled muscarinic receptors is independent of receptor internalization and β-arrestin recruitment.

Guzmán Sánchez-Fernández, Sofía Cabezudo, Carlota García-Hoz, Andrew B Tobin, Federico Mayor, Catalina Ribas

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. OXTRNature communications · 2022
    Article
  2. Article
  3. Biochemical and physiological insights into TRH receptor-mediated signaling.Frontiers in cell and developmental biology · 2022
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Guzmán Sánchez-FernándezDepartamento de Biología Molecular and Centro de Biología Molecular "Severo Ochoa", Universidad Autónoma de Madrid, UAM-CSIC, Madrid, Spain ; Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.
Sofía CabezudoDepartamento de Biología Molecular and Centro de Biología Molecular "Severo Ochoa", Universidad Autónoma de Madrid, UAM-CSIC, Madrid, Spain ; Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.
Carlota García-HozDepartamento de Biología Molecular and Centro de Biología Molecular "Severo Ochoa", Universidad Autónoma de Madrid, UAM-CSIC, Madrid, Spain ; Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.
Andrew B TobinMedical Research Council Toxicology Unit, University of Leicester, Leicester, United Kingdom.
Federico MayorDepartamento de Biología Molecular and Centro de Biología Molecular "Severo Ochoa", Universidad Autónoma de Madrid, UAM-CSIC, Madrid, Spain ; Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.
Catalina RibasDepartamento de Biología Molecular and Centro de Biología Molecular "Severo Ochoa", Universidad Autónoma de Madrid, UAM-CSIC, Madrid, Spain ; Instituto de Investigación Sanitaria La Princesa, Madrid, Spain.
Hospital Universitario de La Princesa · ESUniversidad Autónoma de Madrid · ESCentro de Biología Molecular Severo Ochoa · ESUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G-protein-coupled receptors (GPCRs) are known to activate both G protein- and β-arrestin-dependent signalling cascades. The initiation of mitogen-activated protein kinase (MAPK) pathways is a key downstream event in the control of cellular functions including proliferation, differentiation, migration and apoptosis. Both G proteins and β-arrestins have been reported to mediate context-specific activation of ERK1/2, p38 and JNK MAPKs. Recently, the activation of ERK5 MAPK by Gq-coupled receptors has been described to involve a direct interaction between Gαq and two novel effectors, PKCζ and MEK5. However, the possible contribution of β-arrestin towards this pathway has not yet been addressed. In the present work we sought to investigate the role of receptor internalization processes and β-arrestin recruitment in the activation of ERK5 by Gq-coupled GPCRs. Our results show that ERK5 activation is independent of M1 or M3 muscarinic receptor internalization. Furthermore, we demonstrate that phosphorylation-deficient muscarinic M1 and M3 receptors are still able to fully activate the ERK5 pathway, despite their reported inability to recruit β-arrestins. Indeed, the overexpression of Gαq, but not that of β-arrestin1 or β-arrestin2, was found to potently enhance ERK5 activation by GPCRs, whereas silencing of β-arrestin2 expression did not affect the activation of this pathway. Finally, we show that a β-arrestin-biased mutant form of angiotensin II (SII; Sar1-Ile4-Ile8 AngII) failed to promote ERK5 phosphorylation in primary cardiac fibroblasts, as compared to the natural ligand. Overall, this study shows that the activation of ERK5 MAPK by model Gq-coupled GPCRs does not depend on receptor internalization, β-arrestin recruitment or receptor phosphorylation but rather is dependent on Gαq-signalling.

Indexed as

AnimalsArrestinsbeta-ArrestinsCell LineEnzyme ActivationFibroblastsGTP-Binding Protein alpha Subunits, Gq-G11MiceMitogen-Activated Protein Kinase 7PhosphorylationReceptors, MuscarinicSignal TransductionArrestinsbeta-ArrestinsGTP-Binding Protein alpha Subunits, Gq-G11Mitogen-Activated Protein Kinase 7Receptors, Muscarinic

Identifiers

PMID24358341
PMCPMC3866124
OpenAlexW1971410546

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.